Literature DB >> 1036881

[Histological diagnosis, DNA-content and chromatin pattern of breast cancer cases with positive and negative 17-beta-oestradiol receptor binding (author's transl)].

H Sachs, J Winzer.   

Abstract

The DNA-concent of cell nuclei of 45 breast cancer cases of various histological structure has been determined cytophotometrically. With the exception of two gallert carcinomas no DNA-histogram of peridiploid range was found. The average DNA-content was 2--3 times higher as in the control tissue. The standard deviation of undifferentiated solid mammary tumors was the highest measured in this series. 24 of 45 cases had a negative oestrogen receptor binding. This was true in 60% of the undiffierentiated solid breast cancer cases, in 69% of the adenomatous and in 89 respectively 67% of the ones of special histological structure. The heterochromatin content of nuclei was lowest in the group of differentiated mammary cancer (50--60%). In the group of undifferentiated tumors it was 60--70%. So much for now is known about the mechanism of cellular action of 17-beta-oestradiol and the function of eu- and heterochromatin of cell nuclei it is discussed that positive or negative oestrogen hormone receptor binding in mammary tumor cells is probably a biochemical parameter of cytological desintegration. From this point of view these hormon receptors could be of the same value as the index of Barr bodies in breast cancer cells with respect of selection of cases for hormonal therapy. But this has to be analyzed in further studies extensively.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1036881     DOI: 10.1007/BF00667026

Source DB:  PubMed          Journal:  Arch Gynakol        ISSN: 0003-9128


  17 in total

1.  [ON THE SIGNIFICANCE OF BARR'S CELL NUCLEUS BODIES IN FEMALE BREAST CANCER].

Authors:  F GROSS; W MAHRINGER; H TREBBIN; A BOHLE
Journal:  Dtsch Med Wochenschr       Date:  1964-06-19       Impact factor: 0.628

2.  The cellular distribution of deoxyribonucleic acid in primary and secondary growths of human breast cancer.

Authors:  E S MEEK
Journal:  J Pathol Bacteriol       Date:  1961-07

3.  [The importance of estrogen receptors in the pharmacotherapy of mammary carcinoma (author's transl)].

Authors:  H M Bolt
Journal:  MMW Munch Med Wochenschr       Date:  1975-02-28

4.  [Receptors for polypeptide hormones. Physiologic and pathogenetic significance].

Authors:  J Frowein; K G Petersen
Journal:  Dtsch Med Wochenschr       Date:  1976-04-16       Impact factor: 0.628

5.  DNA in heterochromatin cytophotometric pattern recognition image analysis among cell nuclei in duct epithelium and in carcinoma of the human breast.

Authors:  W Sandritter; G Kiefer; R Kiefer; R Salm; G W Moore; H Grimm
Journal:  Beitr Pathol       Date:  1974-01

Review 6.  [Action mechanism of steroid hormones].

Authors:  P Karlson; C E Sekeris
Journal:  Dtsch Med Wochenschr       Date:  1973-04-20       Impact factor: 0.628

7.  [Cytophotometric study of precancerous lesions of the female breast].

Authors:  H Sachs
Journal:  Beitr Pathol       Date:  1971-07

8.  [On the biological behavior of mammary carcinoma according to the histological type].

Authors:  G Möbius; G Wittstock
Journal:  Frankf Z Pathol       Date:  1965

9.  Estrogen receptors in human breast cancer.

Authors:  W L McGuire
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

10.  Oestrogen receptor in human breast cancer tissue and response to endocrine therapy.

Authors:  E Engelsman; J P Persijn; C B Korsten; F J Cleton
Journal:  Br Med J       Date:  1973-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.